Overview
WittGen Biotechnologies utilizes a single-cell RNA sequencing data analysis and testing to overcome the heterogeneity of cancer. The company offers services that includes prediction of subtypes, grade, and cell composition, SNV, CNV, cancer origin tracking, risk score with pathway analysis, drug recommendation, and novel biomarker identification. WittGen Biotechnologies was founded in 2023 and is based in Berkeley, California.
Tech Stack
Common crawlCommoncrawl top 50mAIAmazon AWSAmazon CloudFrontAndroidCanvaGmailGoogle AppsMobile FriendlyPythonReact NativeRemoteRoute 53
Funding History
Seed Round
Undisclosed
Jun 2023
Plug and Play